Table 2.
Demographics characters and univariate analysis of participants (N=261)
| variables | Number (％) | BHL score (Mean ± SD) | t/F | P |
|---|---|---|---|---|
| Age(years) | 4.875 | ＜0.001 | ||
| 45-55 | 152（58.2） | 44.92±6.59 | ||
| ≥56 | 109（41.8） | 40.66±7.38 | ||
| Educational level | 69.263 | ＜0.001 | ||
| Junior secondary and less | 93（35.6） | 35.67±5.66 | ||
| High school/junior college | 101（38.7） | 40.53±5.33 | ||
| Bachelor and more | 67（25.7） | 42.68±5.84 | ||
| Occupational status | 24.083 | ＜0.001 | ||
| Be employed | 105（40.2） | 45.43±6.74 | ||
| Separation/retirement | 65（24.9） | 44.88±7.23 | ||
| Full-time at home | 91（34.9） | 39.23±6.12 | ||
| Marital status | ||||
| Married | 246(94.3) | 43.29±7.19 | ||
| Unmarried | 5(1.9) | 43.40±5.27 | ||
| divorced/widowed | 10(3.8) | 39.10±8.41 | ||
| Monthly income，RMB | ||||
| ＜3000 | 61（23.4） | 39.05±5.53 | 20.508 | ＜0.001 |
| 3000-5000 | 101（38.7） | 42.75±7.78 | ||
| ＞5000 | 99（37.9） | 46.03±6.25 | ||
| Residence | 7.536 | ＜0.001 | ||
| City | 178（68.2） | 45.22±6.72 | ||
| Village | 83（31.8） | 38.65±6.21 | ||
| TNM stage | 1.65 | 0.194 | ||
| Stage I | 75（28.7） | 44.20±6.89 | ||
| Stage Ⅱ | 115（44.1） | 42.30±7.25 | ||
| Stage Ⅲ | 71（27.2） | 43.37±7.47 | ||
| Duration of endocrine therapy (months) | 1.878 | 0.134 | ||
| ≤12 | 83（31.8） | 42.43±6.83 | ||
| 13-24 | 59（22.6） | 42.58±7.31 | ||
| 25-36 | 38（14.6） | 45.61±6.61 | ||
| ＞36 | 81（31） | 43.09±7.71 | ||
| Endocrine drugs | 2.634 | 0.035 | ||
| Tamoxifen | 36（13.8） | 41.94±5.79 | ||
| Exemestane | 122（46.7） | 42.63±7.58 | ||
| Toremifene | 34（13） | 46.74±6.57 | ||
| Anastrozole | 36（13.8） | 43.19±7.03 | ||
| Letrozole | 33（12.6） | 42.48±7.46 | ||
| Radiotherapy | -1.798 | 0.086 | ||
| Yes | 241（92.3） | 42.90±7.19 | ||
| No | 20（7.7） | 45.95±7.31 |